GTS Securities’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-92,000
Closed -$8.28M 2937
2024
Q3
$8.28M Buy
92,000
+26,900
+41% +$2.26M 0.02% 593
2024
Q2
$5.12M Sell
65,100
-29,800
-31% -$2.44M 0.01% 848
2024
Q1
$8.27M Sell
94,900
-60,400
-39% -$5.15M 0.02% 600
2023
Q4
$12.8M Sell
155,300
-53,400
-26% -$4.07M 0.02% 505
2023
Q3
$16.4M Buy
+208,700
New +$17.5M 0.03% 393

Other funds holding MDT

GTS Securities's MDT Position: Q1 2026 in Review

GTS Securities reduced its Medtronic (MDT) stake by 56% in Q1 2026, selling an estimated $760K and leaving 6,345 shares worth $550K. The position accounts for 0.02% of the portfolio, ranked #687.

GTS Securities first reported a position in MDT in Q3 2023 and has held it in 11 quarters since. The position peaked at $7.82M in Q4 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • GTS Securities held 6,345 shares of Medtronic worth $550K as of Q1 2026.
  • GTS Securities sold 7,936 Medtronic shares in Q1 2026, an estimated $760K.
  • Medtronic made up 0.02% of GTS Securities's portfolio in Q1 2026, its #687 holding.
  • GTS Securities first reported a position in Medtronic in Q3 2023 and has held it in 11 quarters since.
  • GTS Securities's Medtronic position peaked at $7.82M in Q4 2023.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.